Skip to main content
. 2019 Apr 2;321(13):1286–1294. doi: 10.1001/jama.2019.2000

Table 1. Patient Characteristics.

Characteristic Level of Impairment
Mild Cognitive Impairment (n = 6905) Dementia (n = 4504)
Age, median (IQR), y 75 (70-79) 77 (72-81)
Sex, No. (%)
Women 3425 (49.6) 2379 (52.8)
Men 3480 (50.4) 2125 (47.2)
Race, No. (%)a
Black or African American 206 (3.0) 225 (5.0)
White 6212 (90.0) 3828 (85.0)
Other race 487 (7.1) 451 (10.0)
Hispanic ethnicity, No. (%)b 209 (3.0) 244 (5.4)
Highest level of education, No. (%)
High school graduate (including equivalency) or less 1824 (26.4) 1917 (42.6)
Some college or associate degree 1763 (25.5) 933 (20.7)
Bachelor’s degree 1777 (25.7) 927 (20.6)
Postgraduate degree 1541 (22.3) 727 (16.1)
MMSE, median (IQR)c 27 (25-29) 22 (18-25)
MoCA, median (IQR)c 23 (21-25) 18 (14-21)
Alzheimer disease leading suspected pre-PET etiology, No. (%) 5043 (73.0) 3727 (82.7)
Taking Alzheimer disease drugs at enrollment, No. (%) 2384 (34.5) 2671 (59.3)
Amyloid PET results, No. (%)d
Positive 3817 (55.3) 3154 (70.1)
Negative 3082 (44.7) 1347 (29.9)

Abbreviations: IQR, interquartile range; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; PET, positron emission tomography.

a

Race as recorded by dementia specialist, study coordinator, or practice administrator. “Other race” indicates American Indian, Asian, Native Hawaiian or Pacific Islander, unknown, or not reported.

b

Ethnicity as recorded by dementia specialist, study coordinator, or practice administrator; grouped as Hispanic and other (not Hispanic, unknown, or not reported).

c

Range, 0-30; lower scores indicate worse global cognition.

d

Nine cases with uninterpretable test results not included (6 in MCI group, 3 in dementia group).